16 results on '"Damante, Mark"'
Search Results
2. Surgical Characteristics of Intracranial Biopsy Using a Frameless Stereotactic Robotic Platform: A Single-Center Experience.
- Author
-
Kreatsoulas, Daniel C, Vignolles-Jeong, Joshua, Ambreen, Yamenah, Damante, Mark, Akhter, Asad, Lonser, Russell R., and Elder, J. Bradley
- Published
- 2024
- Full Text
- View/download PDF
3. Endoscopic Endonasal Transpterygoid Approach and the Need for Myringotomy.
- Author
-
Damante, Mark A., Magill, Stephen T., Kreatsoulas, Daniel, McGahan, Ben G., Hardesty, Douglas, Carrau, Ricardo L., and Prevedello, Daniel M.
- Abstract
Objective: The expanded endonasal transpterygoid approach (EETA) is used to access the middle and posterior fossa through the pterygoid process. Traditionally, the eustachian tube (ET) was resected during EETA, which often required subsequent myringotomy for inner ear drainage. Anterolateral transposition of the ET was proposed to decrease potential morbidity associated with resection. However, a comparison of resection versus transposition regarding the need for subsequent myringotomy has not been reported. Methods: This is a retrospective cohort study of patients who underwent an EETA. Patient demographics, tumor characteristics, management of ET with resection versus transposition, and need for subsequent myringotomy were collected. Analysis was performed with JMP software in standard fashion and univariate and multivariate logistic regression analysis performed with a p < 0.05 was considered significant. Results: Ninety‐one patients underwent EETA for various malignant and benign tumors. Twenty‐seven patients required myringotomy, with tumors of the pterygopalatine fossa accounting for the most common location (n = 8). Malignant pathology had the highest myringotomy rate compared to benign tumors (48.9% vs. 10.9%, p < 0.001), as did receiving postoperative radiation (p < 0.001), ET resection (p < 0.001), and increasing CPK class. Multivariate analysis of these variables suggests that only ET resection significantly correlated with the need for myringotomy (LR 7.97, p = 0.005). Conclusions: ET resection during EETA can lead to ET dysfunction and require myringotomy post‐operatively, and patients should be counseled of this risk. Radiation treatment, malignant pathology, and CPK class, all reflecting situations where more extensive surgery was needed, were associated with the need for myringotomy on univariate analysis but did not reach significance with multivariate analysis. Level of Evidence: 4 Laryngoscope, 134:1203–1207, 2024 [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Intradural Pituitary Hemitransposition: Technical Note and Case Series Illustration.
- Author
-
Almeida, Joao Paulo, Finger, Guilherme, Weber, Matthieu D., Damante, Mark A., Wu, Kyle C., Walz, Patrick, Leonard, Jeffrey R., Carrau, Ricardo L., and Prevedello, Daniel M.
- Subjects
PITUITARY gland ,CONFLICT of interests - Abstract
The article titled "Intradural Pituitary Hemitransposition: Technical Note and Case Series Illustration" discusses the challenges of accessing lesions in the retrosellar, interpeduncular cistern, and petroclival regions in neurosurgery. The authors propose the endonasal endoscopic intradural pituitary hemitransposition approach as an effective technique for resecting these lesions while preserving pituitary function. The approach involves mobilizing the pituitary gland to safely access the interpeduncular fossa through a midline transsphenoidal route. The article is authored by Joao Paulo Almeida, Guilherme Finger, Matthieu D. Weber, Mark A. Damante, Kyle C. Wu, Patrick Walz, Jeffrey R. Leonard, Ricardo L. Carrau, and Daniel M. Prevedello. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
5. A Modern Approach to Olfactory Groove Meningiomas.
- Author
-
Damante, Mark A., Magill, Stephen T., Kreatsoulas, Daniel, Finger, Guillherme, McGahan, Ben, Hatef, Jeffrey, Hatef, Angel, Carrau, Ricardo L., Hardesty, Douglas, and Prevedello, Daniel M.
- Subjects
SMELL ,CEREBROSPINAL fluid leak ,OPTIC nerve - Abstract
This article discusses the management of olfactory groove meningiomas (OGM) using different surgical approaches. The extended endonasal approach (EEA) is effective for patients with anosmia, as it allows for early devascularization and minimizes retraction on the frontal lobes. However, it has limitations in reaching tumors extending laterally beyond the optic nerves. Craniotomy, on the other hand, is better for preserving olfaction and reaching tumors outside the reach of EEA. A staged approach combining EEA and craniotomy may be a safe and effective option for large OGM with anosmia and significant lateral extension. The study found high rates of gross total resection and resolution of T2/FLAIR hyperintensity with this approach. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
6. Endoscopic Endonasal Transpterygoid Approach and the Need for Myringotomy.
- Author
-
Damante, Mark A, Magill, Stephen T., Kreatsoulas, Daniel, Finger, Guilherme, McGahan, Ben, Hardesty, Douglas, Carrau, Ricardo, and Prevedello, Daniel M.
- Subjects
MYRINGOTOMY ,INNER ear - Abstract
This article discusses the use of the expanded endonasal transpterygoid approach (EETA) in accessing the middle and posterior fossa through the pterygoid process. Traditionally, the eustachian tube (ET) was resected during EETA, which often required subsequent myringotomy for inner ear drainage. However, anterolateral transposition of the ET has been proposed as an alternative to decrease potential morbidity. This retrospective cohort study found that ET resection during EETA was significantly correlated with the need for myringotomy post-operatively. Patients should be counseled about this risk, while other factors such as radiation treatment, malignant pathology, and CPK class were associated with the need for myringotomy but did not reach significance in multivariate analysis. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
7. Adjuvant convection-enhanced delivery for the treatment of brain tumors.
- Author
-
Kreatsoulas, Daniel, Damante, Mark, Cua, Santino, and Lonser, Russell R.
- Abstract
Background: Malignant gliomas are a therapeutic challenge and remain nearly uniformly fatal. While new targeted chemotherapeutic agentsagainst malignant glioma have been developed in vitro, these putative therapeutics have not been translated into successful clinical treatments. The lack of clinical effectiveness can be the result of ineffective biologic strategies, heterogeneous tumor targets and/or the result of poortherapeutic distribution to malignant glioma cells using conventional nervous system delivery modalities (intravascular, cerebrospinal fluid and/orpolymer implantation), and/or ineffective biologic strategies. Methods: The authors performed a review of the literature for the terms "convection enhanced delivery", "glioblastoma", and "glioma". Selectclinical trials were summarized based on their various biological mechanisms and technological innovation, focusing on more recently publisheddata when possible. Results: We describe the properties, features and landmark clinical trials associated with convection-enhanced delivery for malignant gliomas.We also discuss future trends that will be vital to CED innovation and improvement. Conclusion: Efficacy of CED for malignant glioma to date has been mixed, but improvements in technology and therapeutic agents arepromising. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Epileptic versus neuro-oncological focus of management in pediatric patients with concurrent primary brain lesion and seizures: a systematic review.
- Author
-
Gruber, Maxwell D., Pindrik, Jonathan, Damante, Mark, Schulz, Lauren, Shaikhouni, Ammar, and Leonard, Jeffrey R.
- Published
- 2023
- Full Text
- View/download PDF
9. Neoadjuvant Arterial Embolization of Spine Metastases Associated With Improved Local Control in Patients Receiving Surgical Decompression and Stereotactic Body Radiotherapy.
- Author
-
Damante, Mark A., Gibbs, David, Dibs, Khaled, Palmer, Joshua D., Raval, Raju, Scharschmidt, Thomas, Chakravarti, Arnab, Bourekas, Eric, Boulter, Daniel, Thomas, Evan, Grecula, John, Beyer, Sasha, Xu, David, Nimjee, Shahid, Youssef, Patrick, Lonser, Russell, Blakaj, Dukagjin M., and Elder, J. Bradley
- Published
- 2023
- Full Text
- View/download PDF
10. Association between systemic treatment with immune checkpoint inhibitor therapy in renal cell carcinoma and reduced risk of brain metastasis development.
- Author
-
Damante, Mark, Huntoon, Kristin, Gibbs, David, Pezzutti, Dante, Olencki, Thomas, and Elder, J. Bradley
- Published
- 2023
- Full Text
- View/download PDF
11. Supratotal Surgical Resection for Low-Grade Glioma: A Systematic Review.
- Author
-
Kreatsoulas, Daniel, Damante, Mark, Gruber, Maxwell, Duru, Olivia, and Elder, James Bradley
- Subjects
ONLINE information services ,MEDICAL databases ,DISEASE progression ,NEUROPSYCHOLOGY ,OPERATIVE surgery ,SYSTEMATIC reviews ,GLIOMAS ,SURGICAL complications ,TREATMENT effectiveness ,MEDLINE ,SEIZURES (Medicine) ,PROGRESSION-free survival ,TUMOR grading ,OVERALL survival ,PATIENT safety - Abstract
Simple Summary: Low-grade gliomas are slow-growing, progressive tumors of the brain that invariably become high grade. They present a challenging entity because they can invade normal brain without many changes on radiologic scans. Standard treatment involves maximal safe removal via surgery, then close monitoring or other treatments, depending on whether portions were left. Some authors recommend removing a larger area of the brain than can be seen as tumor on imaging (called supratotal resection) because it theoretically gives patients a potential for longer disease-free survival. However, removing the adjacent "normal" brain carries the risk of neurological harm, which has tempered widespread adoption of the supratotal technique in lieu of preserving patients' function. In this review, literature surrounding supratotal resection is explored systematically, and while there are no randomized trials, some evidence may suggest that supratotal resection is safe and effective as standard resection. Further studies are required to fully answer this question. Low-grade gliomas (LGGs) are optimally treated with up-front maximal safe surgical resection, typically defined as maximizing the extent of tumor resection while minimizing neurologic risks of surgery. Supratotal resection of LGG may improve outcomes beyond gross total resection by removing tumor cells invading beyond the tumor border as defined on MRI. However, the evidence regarding supratotal resection of LGG, in terms of impact on clinical outcomes, such as overall survival and neurologic morbidities, remains unclear. Authors independently searched the PubMed, Medline, Ovid, CENTRAL (Cochrane Central Register of Controlled Trials), and Google Scholar databases for studies evaluating overall survival, time to progression, seizure outcomes, and postoperative neurologic and medical complications of supratotal resection/FLAIRectomy of WHO-defined LGGs. Papers in languages other than English, lacking full-text availability, evaluating supratotal resection of WHO-defined high-grade gliomas only, and nonhuman studies were excluded. After literature search, reference screening, and initial exclusions, 65 studies were screened for relevancy, of which 23 were evaluated via full-text review, and 10 were ultimately included in the final evidence review. Studies were evaluated for quality using the MINORS criteria. After data extraction, a total of 1301 LGG patients were included in the analysis, with 377 (29.0%) undergoing supratotal resection. The main measured outcomes were extent of resection, pre- and postoperative neurological deficits, seizure control, adjuvant treatment, neuropsychological outcomes, ability to return to work, progression-free survival, and overall survival. Overall, low- to moderate-quality evidence was supportive of aggressive, functional boundary-based resection of LGGs due to improvements in progression-free survival and seizure control. The published literature provides a moderate amount of low-quality evidence supporting supratotal surgical resection along functional boundaries for low-grade glioma. Among patients included in this analysis, the occurrence of postoperative neurological deficits was low, and nearly all patients recovered within 3 to 6 months after surgery. Notably, the surgical centers represented in this analysis have significant experience in glioma surgery in general, and supratotal resection specifically. In this setting, supratotal surgical resection along functional boundaries appears to be appropriate for both symptomatic and asymptomatic low-grade glioma patients. Larger clinical studies are needed to better define the role of supratotal resection in LGG. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis.
- Author
-
Palmer, Joshua D., Perlow, Haley K., Matsui, Jennifer K., Ho, Cindy, Prasad, Rahul N., Liu, Kevin, Upadhyay, Rituraj, Klamer, Brett, Wang, Joshua, Damante, Mark, Ghose, Jayeeta, Blakaj, Dukagjin M., Beyer, Sasha, Grecula, John, Arnett, Andrea, Thomas, Evan, Chakravarti, Arnab, Lonser, Russell, Hardesty, Douglas, and Prevedello, Daniel
- Abstract
Background: The current standard of care for patients with a large brain metastasis and limited intracranial disease burden is surgical resection and post-operative single fraction stereotactic radiosurgery (SRS). However, post-operative SRS can still lead to substantial rates of local failure (LF), radiation necrosis (RN), and meningeal disease (MD). Pre-operative SRS may reduce the risk of RN and MD, while fractionated treatments may improve local control by allowing delivery of higher biological effective dose. We hypothesize that pre-operative fractionated stereotactic radiation therapy (FSRT) can minimize rates of LF, RN, and MD. Methods: A retrospective, multi-institutional analysis was conducted and included patients who had pre-operative FSRT for a large or symptomatic brain metastasis. Pertinent demographic, clinical, radiation, surgical, and follow up data were collected for each patient. A primary measurement was the rate of a composite endpoint of (1) LF, (2) MD, and/or (3) Grade 2 or higher (symptomatic) RN. Results: 53 patients with 55 lesions were eligible for analysis. FSRT was prescribed to a dose of 24–25 Gy in 3–5 fractions. There were 0 LFs, 3 Grade 2–3 RN events, and 1 MD occurrence, which corresponded to an 8% per-patient composite endpoint event rate. Conclusions: In this study, the composite endpoint of 8% for pre-operative FSRT was improved compared to previously reported rates with post-operative SRS of 49–60% (N107C, Mahajan etal. JCOG0504) and pre-operative SRS endpoints of 20.6% (PROPS-BM). Pre-operative FSRT appears to be safe, effective, and may decrease the incidence of adverse outcomes. Prospective validation is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. A Case Report of Siblings with Dystonia: A Potential Link Between DYT11 Mutation and Platelet Dysfunction.
- Author
-
Damante, Mark, Ganguly, Ranjit, Huntoon, Kristin, Kraut, Eric, Deogaonkar, Milind, Damante, Mark A, Huntoon, Kristin M, and Kraut, Eric H
- Abstract
Myoclonus-dystonia syndrome (MDS) is an autosomal dominant disorder due to a mutated epsilon-sarcoglycan gene (SGCE) at the dystonia 11 (DYT11) locus on chromosome 7q21-31. ε-sarcoglycan has been identified in vascular smooth muscle and has been suggested to stabilize the capillary system. This report describes two siblings with MDS treated with bilateral globus pallidus interna deep brain stimulation. One patient had a history of bleeding following dental procedures, menorrhagia, and DBS placement complicated by intraoperative bleeding during cannula insertion. The other sibling endorsed frequent epistaxis. Subsequent procedures were typically treated perioperatively with platelet or tranexamic acid transfusion. Hematologic workup showed chronic borderline thrombocytopenia but did not elucidate a cause-specific platelet dysfunction or underlying coagulopathy. The bleeding history and thrombocytopenia observed suggest a potential link between MDS and platelet dysfunction. Mutated ε-sarcoglycan may destabilize the capillary system, thus impairing vasoconstriction and leading to suboptimal platelet aggregation. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Venous infarction secondary to congestive encephalopathy from central venous occlusive disease in a chronic hemodialysis patient: A case report.
- Author
-
Damante, Mark A., Huntoon, Kristin M., Schunemann, Victoria A., Ikeda, Daniel S., and Youssef, Patrick P.
- Subjects
HEMODIALYSIS ,BRAIN diseases ,INFARCTION ,HEMIPARESIS ,MENTAL status examination - Abstract
Central venous occlusive disease secondary to chronic hemodialysis catheterization rarely progresses to encephalopathy, cerebral infarction, and/or hemorrhage. A 59-year-old male with 15 years of haemodialysis-dependent end-stage renal disease presented with acutely altered mental status, extensor rigidity with left hemiparesis and equal, but small and nonreactive pupils. Magnetic resonance imaging demonstrated infarction and cerebral edema. Cranial angiogram through right brachial artery injection revealed right subclavian vein opacification via a patent AV-fistula and retrograde flow to the right internal jugular vein and superior sagittal sinus secondary to occlusion of the brachiocephalic vein. All cerebral and right upper extremity venous drainage occurred via the contralateral venous outflow tract. Internal carotid artery injections revealed significant venous congestion. Despite successful angioplasty with stenting and resolution of venous flow reversal, the patient failed to recover neurologically. The devastating nature of the presented case emphasizes the need for frequent neurologic evaluation of such patients to avoid catastrophic cerebrovascular injury. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
15. Intraoperative 3 T MRI is more correlative to residual disease extent than early postoperative MRI.
- Author
-
Huntoon, Kristin, Makary, Mina S., Damante, Mark, Giglio, Pierre, Slone, Wayne, and Elder, J. Bradley
- Abstract
Purpose: Extent of resection of low grade glioma (LGG) is an important prognostic variable, and may influence decisions regarding adjuvant therapy in certain patient populations. Immediate postoperative magnetic resonance image (MRI) is the mainstay for assessing residual tumor. However, previous studies have suggested that early postoperative MRI fluid-attenuated inversion recovery (FLAIR) (within 48 h) may overestimate residual tumor volume in LGG. Intraoperative magnetic resonance imaging (iMRI) without subsequent resection may more accurately assess residual tumor. Consistency in MRI techniques and utilization of higher magnet strengths may further improve both comparisons between MRI studies performed at different time points as well as the specificity of MRI findings to identify residual tumor. To evaluate the utility of 3 T iMRI in the imaging of LGG, we volumetrically analyzed intraoperative, early, and late (~ 3 months after surgery) postoperative MRIs after resection of LGG. Methods: A total of 32 patients with LGG were assessed retrospectively. Residual tumor was defined as hyperintense T2 signal on FLAIR. Volumetric assessment was performed with intraoperative, early, and late postoperative FLAIR via TeraRecon iNtuition. Results: Perilesional FLAIR parenchymal abnormality volumes were significantly different comparing intraoperative and early postoperative MRI (2.17 ± 0.45 cm
3 vs. 5.47 ± 1.07 cm3 , respectively (p = 0.0002)). A significant difference of perilesional FLAIR parenchymal abnormality volumes was also found comparing early and late postoperative MRI (5.47 ± 1.07 cm3 vs. 3.22 ± 0.64 cm3 , respectively (p = 0.0001)). There was no significant difference between intraoperative and late postoperative Perilesional FLAIR parenchymal abnormality volumes. Conclusions: Intraoperative 3 T MRI without further resection appears to better reflect the volume of residual tumor in LGG compared with early postoperative 3 T MRI. Early postoperative MRI may overestimate residual tumor. As such, intraoperative MRI performed after completion of tumor resection may be more useful for making decisions regarding adjuvant therapy. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
16. A case of multiple synchronously diagnosed brain metastases from alveolar soft part sarcoma without concurrent lung involvement.
- Author
-
Damante, Mark A., Huntoon, Kristin M., Palmer, Joshua D., Liebner, David A., and Elder, James Bradley
- Subjects
BRAIN metastasis ,PROGRAMMED death-ligand 1 ,PROGNOSIS ,DRUG efficacy ,SARCOMA - Abstract
Background: Alveolar soft part sarcoma (ASPS) is a rare soft-tissue sarcoma with a propensity for early hematogenous dissemination to the lungs and frequent brain metastasis. The development of lung metastasis almost invariably precedes intracranial involvement. There are no previously reported cases in which a patient was synchronously diagnosed with ASPS and multiple brain metastasis without lung involvement. Case Description: A 29-year-old gentleman was found to have three intracranial lesions following the onset of generalized seizures. Staging studies identified a soft-tissue mass in the left thigh and an adjacent femoral lesion. Biopsy of the soft-tissue mass was consistent with ASPS. The patient then underwent neoadjuvant stereotactic radiotherapy to all three brain lesions, followed by en bloc resection of the dominant lesion. The patient was then started on a programmed death-ligand 1 (PD-L1) inhibitor. Subsequent surgical resection of the primary lesion and femur metastasis demonstrates a histopathologic complete response of the bony metastasis and partial response of the primary lesion. At present, the patient has received 14 cycles of atezolizumab without recurrence of the primary or bony lesions and the irradiated intracranial disease has remained stable without recurrence of the resected dominant lesion. Conclusion: While intracranial involvement is relatively common in ASPS, a case with multiple, synchronously diagnosed brain metastasis without concurrent lung metastasis has not been described. The presented case discusses the safety and efficacy of aggressive management of intracranial disease in the setting of atezolizumab. Prospective evaluation of the efficacy of checkpoint inhibitors and the prognostic value of PD-L1 expression in ASPS with brain metastasis are necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.